ANRO

ANRO Operating Cash Flow (Statement)

-$68.29MTTM · USD

Period ending:

ANRO FY Cash from OperationsUSD
ANRO FY Cash from Operations2021-12-31: -$9.26M2022-12-31: -$20.39M2023-12-31: -$33.45M2024-12-31: -$47.42M2025-12-31: -$51.77M$0.00-$51.77M
2021-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ANRO operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 5 observations from Dec 31, 2021 to Dec 31, 2025.

Alto Neuroscience, Inc. Common Stock Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-51,769,000
-47,424,000
-33,448,000
-20,394,000
-9,262,000

Compare operating cash flow (statement)

All ANRO financial metrics · ANRO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.